Bridgeway Capital Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,625
Closed -$84K 1323
2024
Q3
$84K Hold
4,625
﹤0.01% 1174
2024
Q2
$112K Hold
4,625
﹤0.01% 1154
2024
Q1
$202K Sell
4,625
-2,500
-35% -$104K ﹤0.01% 1108
2023
Q4
$291K Buy
7,125
+5,625
+375% +$306K 0.01% 1066
2023
Q3
$124K Sell
1,500
-1,625
-52% -$147K ﹤0.01% 1186
2023
Q2
$298K Sell
3,125
-903
-22% -$116K 0.01% 1049
2023
Q1
$556K Buy
+4,028
New +$368K 0.01% 861

Other funds holding DNMR

Bridgeway Capital Management's DNMR Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 4,625 shares — an estimated $84K sold.

Bridgeway Capital Management first reported a position in DNMR in Q1 2023 and held it in 7 quarters. The position peaked at $556K in Q1 2023. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Bridgeway Capital Management reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 4,625 Danimer Scientific, Inc. shares in Q4 2024, an estimated $84K.
  • Bridgeway Capital Management first reported a position in Danimer Scientific, Inc. in Q1 2023 and held it in 7 quarters.
  • Bridgeway Capital Management's Danimer Scientific, Inc. position peaked at $556K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.